Compounders Research Compare

CalciMedica, Inc.(CALC)

Biotechnology · La Jolla, CA

$1.57+0.03 (+1.95%)

Delayed quote: Oct 6, 2026, 12:20 PM EDT

About CalciMedica, Inc.

CalciMedica, Inc., a clinical-stage biotechnology company headquartered in La Jolla, California, is focused on creating treatments for life-threatening inflammatory diseases that currently lack adequate therapies. The company's proprietary approach involves blocking calcium release-activated (CRAC) channels, a mechanism designed to modulate the immune system and protect against cellular and tissue damage in these severe conditions. Their primary experimental drug, Auxora, is an intravenously administered, proprietary CRAC channel inhibitor being developed for the treatment of acute pancreatitis, including its asparaginase-associated form, and acute kidney injury.

La Jolla, CA

15 employees

www.calcimedica.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: A. Rachel Leheny

View full financials

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T16:26:03.293Z.

Stored calculation inputs

Calculation as of: 2026-10-06T16:26:03.293Z.

Quote observation: 2026-10-06T16:20:20.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -6.95
Quote price: 1.57

FMP input reference: e9e072c721023a8f5b36c3f5b81ac18026d6678c99aa2a087bce1e48ab153e53

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

CALC Earnings Yield Metrics

EARNINGS YIELD

N/A

CALC Competitors' Earnings Yield

CalciMedica, Inc.

Current

Market Cap

$4.94M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Imunon, Inc.

Market Cap

$4.98M

Earnings Yield

N/A

TTM Avg

63.50%

3Y Avg

63.50%

5Y Avg

63.50%

Lexaria Bioscience Corp.

Market Cap

$4.84M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Liminatus Pharma, Inc. Class A Common Stock

Market Cap

$5.17M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Basel Medical Group Ltd Ordinary Shares

Market Cap

$5.20M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Alzamend Neuro Inc

Market Cap

$5.21M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Lunai Bioworks Inc.

Market Cap

$5.21M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Gelteq Limited Ordinary Shares

Market Cap

$5.24M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Pulmatrix, Inc.

Market Cap

$5.24M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Intelligent Bio Solutions Inc.

Market Cap

$5.24M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
CalciMedica, Inc. (CALC)	$4.94M	N/A	N/A	N/A	N/A
Imunon, Inc. (IMNN)vs ›	$4.98M	N/A	63.50%	63.50%	63.50%
Lexaria Bioscience Corp. (LEXX)vs ›	$4.84M	N/A	N/A	N/A	N/A
Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs ›	$5.17M	N/A	N/A	N/A	N/A
Basel Medical Group Ltd Ordinary Shares (BMGL)vs ›	$5.20M	N/A	N/A	N/A	N/A
Alzamend Neuro Inc (ALZN)vs ›	$5.21M	N/A	N/A	N/A	N/A
Lunai Bioworks Inc. (LNAI)vs ›	$5.21M	N/A	N/A	N/A	N/A
Gelteq Limited Ordinary Shares (GELS)vs ›	$5.24M	N/A	N/A	N/A	N/A
Pulmatrix, Inc. (PULM)vs ›	$5.24M	N/A	N/A	N/A	N/A
Intelligent Bio Solutions Inc. (INBS)vs ›	$5.24M	N/A	N/A	N/A	N/A

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics